Literature DB >> 7904388

The therapeutic role of sulfated polysaccharides in the urinary bladder.

C L Parsons1.   

Abstract

Polysaccharide therapy for bladder disease is a novel therapy based on the model of bladder mucus activity and the belief that mucus and exogenous glycosaminoglycans (GAG) have protective properties. Interstitial cystitis is the first disease explored for the potential use of polysaccharide therapy, which appears to be effective in some patients with this syndrome.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7904388

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  19 in total

1.  Treatment of refractory interstitial cystitis.

Authors:  A Morales; L Emerson; J C Nickel
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

Review 2.  Recent advances in intravesical drug/gene delivery.

Authors:  Pradeep Tyagi; Pao-Chu Wu; Michael Chancellor; Naoki Yoshimura; Leaf Huang
Journal:  Mol Pharm       Date:  2006 Jul-Aug       Impact factor: 4.939

Review 3.  Urothelial signaling.

Authors:  Lori Birder; Karl-Erik Andersson
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 4.  The Urothelium: Life in a Liquid Environment.

Authors:  Marianela G Dalghi; Nicolas Montalbetti; Marcelo D Carattino; Gerard Apodaca
Journal:  Physiol Rev       Date:  2020-03-19       Impact factor: 37.312

5.  Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey.

Authors:  Antonio Cicione; Francesco Cantiello; Giuseppe Ucciero; Andrea Salonia; Marco Torella; Marco De Sio; Riccardo Autorino; Antonio Carbone; Martin Romancik; Roman Tomaskin; Rocco Damiano
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

Review 6.  Painful bladder syndrome: an update and review of current management strategies.

Authors:  Anthony J Dyer; Christian O Twiss
Journal:  Curr Urol Rep       Date:  2014-02       Impact factor: 3.092

7.  The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease.

Authors:  Rocco Damiano; Antonio Cicione
Journal:  Ther Adv Urol       Date:  2011-10

8.  Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis.

Authors:  A Rosamilia; P L Dwyer; J Gibson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

9.  Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium.

Authors:  Bikramjit Chopra; Stacey R Barrick; Susan Meyers; Jonathan M Beckel; Mark L Zeidel; Anthony P D W Ford; William C de Groat; Lori A Birder
Journal:  J Physiol       Date:  2004-12-02       Impact factor: 5.182

10.  Sequential hydrodistension and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study.

Authors:  Imran Ahmad; Nalagatla Sarath Krishna; Robert N Meddings
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.